Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 93,220 | 94,222 | 69,411 | 69,514 | 79,594 |
| Marketable Securities | 148,305 | 174,964 | 209,846 | 226,696 | 252,125 |
| Receivables | 122,116 | 42,876 | 44,522 | 38,148 | 19,175 |
| Other current assets | 7,197 | 7,271 | 7,032 | 4,199 | 2,414 |
| TOTAL | $386,950 | $329,082 | $338,233 | $345,032 | $360,228 |
| Non-Current Assets | |||||
| PPE Net | 38,871 | 32,696 | 30,414 | 28,973 | 28,287 |
| Investments And Advances | 48,272 | 70,054 | 77,361 | 103,785 | 85,408 |
| Other Non-Current Assets | 67,081 | 17,906 | 17,928 | 20,118 | 35,314 |
| TOTAL | $154,224 | $120,656 | $125,703 | $152,876 | $149,009 |
| Total Assets | $541,174 | $449,738 | $463,936 | $497,908 | $509,237 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,244 | 10,901 | 9,008 | 6,409 | 9,608 |
| Accrued Expenses | 44,356 | 25,839 | 20,327 | 24,846 | 19,231 |
| TOTAL | $63,613 | $40,203 | $31,789 | $33,676 | $31,345 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 449 | 450 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 58,006 | 7,667 | 8,662 | 10,702 | 6,164 |
| TOTAL | $61,901 | $11,674 | $11,995 | $14,035 | $9,497 |
| Total Liabilities | $125,514 | $51,877 | $43,784 | $47,711 | $40,842 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,408 | 37,334 | 37,241 | 37,139 | 36,874 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -242,831 | -251,622 | -217,860 | -177,822 | -151,358 |
| Other shareholders' equity | 263 | 750 | -580 | 205 | 363 |
| TOTAL | $415,660 | $397,861 | $420,152 | $450,197 | $468,395 |
| Total Liabilities And Equity | $541,174 | $449,738 | $463,936 | $497,908 | $509,237 |